Strategic Solution Architecture • Muhrat Al Marasim
Clinical Evaluation & Evidence Generation.
التقييم السريري وتوليد الأدلة الطبية
CER Authoring, GCP Trial Approvals & Post-Market Clinical Follow-Up (PMCF)
Executive Framework
Strategic overview and institutional delivery.
Robust clinical data is imperative for Class IIb and Class III marketing authorizations. We produce state-of-the-art Clinical Evaluation Reports (CER) aligned with MEDDEV 2.7/1 Rev. 4 and EU MDR Article 61.
Strategic Solution Pillars
Clinical Evaluation Reports (CER)
Systematic literature searches, equivalence demonstrations, and clinical safety syntheses by medical writers.
SFDA Clinical Trial Authorizations
Compilation and ethics committee (IRB) clearance for local clinical trials and feasibility studies.
Post-Market Clinical Follow-Up (PMCF)
Designing registries, user surveys, and observational studies to fulfill post-approval conditions.
Measurable Corporate Outcomes
Defensible clinical evidence accepted by SFDA scientific panels
Seamless alignment with European and US post-market data
Unbroken clinical lifecycle continuity
Operational Execution Stepper
Interactive StagesClinical Protocol Design
Formulating systematic appraisal criteria and search strategies.
Solution Proposal Blueprint
Configure Engagement Terms
Tailor the operational scope for Clinical Evaluation & Evidence Generation: